NSE filing, NSE: SAROJA. Summary written from the filing by ALFA Finder's alert engine.
Saroja Pharma Industries India Ltd: key numbers
- Share price
- ₹38.80
- Market cap
- ₹15.60 Cr
- Revenue (annual)
- ₹70.13 Cr
- Net profit (annual)
- ₹1.61 Cr
- P/E (TTM)
- 9.7×Sector 28.2×
- Promoter holding
- 73.02%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Saroja Pharma Industries India Ltd
All →Saroja Pharma Industries India Management Change
Saroja Pharma's statutory auditor Pravin Chandak & Associates resigned effective October 26, 2026, citing pre-occupation. The company will appoint new auditors to fill the vacancy.
Saroja Pharma Industries India Management Change
Mr. Ravindra Shivaji Salaskar has resigned as Whole-time Director of Saroja Pharma Industries India Limited, effective October 5, 2026. He continues as the company's CFO.
Saroja Pharma Industries India Annual General Meeting
Saroja Pharma Industries India Limited held its 8th Annual General Meeting on September 30, 2026, through video conferencing to transact business.
Saroja Pharma Industries India Management Change
Saroja Pharma Industries India Limited appointed Mr. Ravindra Shivaji Salaskar as Chief Financial Officer. He currently serves as a Whole-time Director of the company.
Saroja Pharma Industries India Board Meeting Outcome
Saroja Pharma Industries approved its draft Board Report, Management Discussion and Analysis Report, and the notice for its 8th Annual General Meeting.
Saroja Pharma Industries India Board Meeting Outcome
Saroja Pharma announced the re-designation of Mr. Pulinattu Damodaran Nandakumar as Whole-time Director and the appointment of Mr. Niraj Variava as Internal Auditor.
Other annual general meeting announcements
All →Generic Engineering Construction and Projects Annual General Meeting
Generic Engineering's 32nd AGM is scheduled for November 30, 2026 via VC/OAVM. Agenda includes FY26 financial statements, director reappointment and related-party transactions approval.
Kirloskar Industries Annual General Meeting
Kirloskar Industries forwarded its subsidiary KFIL's postal ballot scrutinizer report. Shareholders passed resolutions appointing Ajay Shriram Patil as a director and as Joint Managing Director.
Umiya Tubes Annual General Meeting
Umiya Tubes submitted voting results and the scrutinizer report for its postal ballot ending 7 November 2026. Resolution 1, alteration of the name clause, passed as a special resolution with 100% of votes cast in favour.
Prime Focus Annual General Meeting
Prime Focus Limited's EOGM held on 7 November 2026 passed all resolutions with requisite majority. Resolutions cover cessation of control over Brahma AI Holdings and related party transactions involving its subsidiaries.
Jagsonpal Services Annual General Meeting
Jagsonpal Services shareholders approved an asset-acquisition business transfer agreement with Elanistech via postal ballot. A name-change certificate was also noted.
Vineet Laboratories Annual General Meeting
Vineet Laboratories has circulated notice of its 10th AGM, scheduled for 30 November 2026 via video conferencing. The filing attaches the FY 2025-26 annual report.